Cancer Biopsy market was valued at US$ 25.75 billion in 2021, and it is expected to grow to US$ 66.5 billion by 2027, with a CAGR of 17.9% between 2022 and 2027.

Industry Data Analytics published a new market research report on Global Cancer Biopsy Market contains all of the market definitions, classifications, segments, applications, engagements, and market trends that a user needs to succeed in the Global Cancer Biopsy Market. The removal of tissue from any part of the body to examine for disease is known as a biopsy. Some may use a needle to extract a small tissue sample, while others may surgically remove a suspicious nodule or lump. Biopsies are commonly used to diagnose cancer, but they can also assist in the identification of other illnesses such as infections and inflammatory and autoimmune disorders. They may also be used to match organ tissue prior to transplantation and to look for signs of organ rejection after transplantation. The report offers in-depth analysis and insights into the current global market scenario, as well as the most recent trends and drivers in the global cancer biopsy market. It provides a unique perspective on market size, key trends, competitive landscape, growth rate, and market segments. This research also examines the impact of the COVID-19 crisis on the cancer biopsy industry.

Request Sample Report:

https://www.industrydataanalytics.com/reports/cancer-biopsy-market/inquiry

The rise in cancer diseases is also driving the expansion of the cancer biopsy market. According to the International Agency for Research on Cancer (IARC), new cancer cases are expected to reach 27.5 million in 2018 and 16.3 million cancer deaths worldwide by 2040. According to the National Cancer Institute (NCI), the estimated number of new bladder cancer cases in 2021 was 83,730, with breast cancer cases accounting for 284,200 and colon and rectal cancer accounting for 149,500 in the United States. This points to a possible increase in the cancer biopsy market in the coming years.

Key Market Segments of Cancer Biopsy Market

By Type:

  • Tissue Biopsies
  • Liquid Biopsies
  • Others

By Application:

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

 

Key Takeaways of Cancer Biopsy Market

• In 2020, North America held the largest share (more than 40.0%). The region is expected to maintain its lead throughout the forecast period, with the United States contributing significantly to regional revenue.

• Key players are contributing to market growth by expanding their diagnostics portfolio, thereby increasing the uptake of their proprietary biopsy products. For example, Illumina, Inc. announced medical device registration for its NextSeq 550Dx platform and associated reagent kits in Russia in March 2021. Prior to this registration, its MiSeq Dx was already approved as a medical device.

Inquire Before Buying Research Report:

https://www.industrydataanalytics.com/reports/en/cancer-biopsy-market

 

Competitive Landscape

With several players worldwide, the Cancer Biopsies market is moderately competitive. Few major players currently dominate the market in terms of market share. With rising patient awareness and the high prevalence of cancer diseases, particularly recent developments in liquid biopsies, many regional players are expected to participate in the cancer biopsies market over the forecast period. The report  provides analysis of the prominent companies of the industry and their detailed company profiles including

·         ANGLE plc, Becton

·         Dickinson and Company

·         Biocept, Inc.

·         Biodesix, Inc. (Integrated Diagnostics)

·         Danaher Corporation

·         Exact Sciences Corporation

·         F. Hoffmann-La Roche AG

·         Freenome Holdings, Inc.

·         GRAIL

·         LLC

·         Guardant Health, Inc.

·         Helio Health Inc.

·         Hologic, Inc.

·         Illumina, Inc.

·         Lucence Health Inc.

·         Myriad Genetics, Inc.

·         Oncimmune Holdings PLC

·         Qiagen N.V.

·         Thermo Fisher Scientific, Inc.

 

About Industry Data Analytics : Industry Data Analytics provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.

Industry Data Analytics provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

 

Contact Us:
Irfan Tamboli (Head of Sales) – Industry Data Analytics
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com